JP Morgan maintains Aveanna Healthcare at Neutral
JP Morgan maintained its Neutral rating on Aveanna Healthcare and raised its price target to $15.00 from $8.00, per Benzinga.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.